Long-Term Outcomes of Active Surveillance for Prostate Cancer - Interview with Sigrid Carlsson
June 12, 2018
Sigrid Carlsson, MD, Ph.D., MPH is the assistant attending epidemiologist at the Memorial Sloan Kettering Cancer Center. Dr. Carlsson’s research is focused on screening and early detection of prostate cancer. She is an investigator in the world’s largest randomized study of screening for prostate cancer, the European Randomized Study of Screening for Prostate Cancer. Dr. Carlsson’s research aims at finding a better balance between the harms and benefits of prostate-specific antigen (PSA) screening, through the use of multiplex testing and risk-stratified strategies that incorporate clinical information, biomarkers, and magnetic resonance imaging.
Alicia Morgans, MD, MPH
Study Discussed in this Conversation:
Long-Term Outcomes of Active Surveillance for Prostate Cancer - Memorial Sloan Kettering Cancer Center Experience